Recent press releases
Sensory bracelet indicates infection two days before appearance of first symptoms Vaduz, March 22, 2021 […]
Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19
Data analysis from earlier COVI-GAPP pilot study shows Ava’s algorithm accurately detected 71% of COVID-19 […]
First and only FDA-cleared fertility tracking wearable clinically proven as effective as LH tests in […]
About AvaAva is a Swiss digital health company that aims to revolutionize women’s health. We have offices in Zurich, San Francisco and Belgrade.
Our fertility-tracking sensor bracelet, app, and proprietary predictive algorithms empower women by providing clinically proven insight about the menstrual cycle, fertile window, and pregnancy—all delivered conveniently and non-invasively. Ava was voted “Best of Baby Tech” at CES 2017, named a Women’s Health “Editors’ Choice” product, and honored as the top Swiss startup in both 2017 and 2018.